BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Menges M, Müller M, Zeitz M. Increased acid and bile reflux in Barrett’s esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. Am J Gastroenterol. 2001;96:331-337. [PMID: 11232672 DOI: 10.1111/j.1572-0241.2001.03515.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 76] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 bredenoord AJ, hemmink GJM, smout AJPM. Relationship between gastro-oesophageal reflux pattern and severity of mucosal damage. Neurogastroenterology & Motility 2009;21:807-12. [DOI: 10.1111/j.1365-2982.2009.01306.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 4.8] [Reference Citation Analysis]
2 Dvorak K, Watts GS, Ramsey L, Holubec H, Payne CM, Bernstein C, Jenkins GJ, Sampliner RE, Prasad A, Garewal HS. Expression of bile acid transporting proteins in Barrett’s esophagus and esophageal adenocarcinoma. Am J Gastroenterol. 2009;104:302-309. [PMID: 19174784 DOI: 10.1038/ajg.2008.85] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
3 Hoffman I, Tertychnyy A, Ectors N, De Greef T, Haesendonck N, Tack J. Duodenogastro-Esophageal Reflux in Children with Refractory Gastro-Esophageal Reflux Disease. The Journal of Pediatrics 2007;151:307-11. [DOI: 10.1016/j.jpeds.2007.03.024] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
4 Fuchs CD, Trauner M. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology. Nat Rev Gastroenterol Hepatol. [DOI: 10.1038/s41575-021-00566-7] [Reference Citation Analysis]
5 Wiseman EF, Ang YS. Risk factors for neoplastic progression in Barrett’s esophagus. World J Gastroenterol 2011; 17(32): 3672-3683 [PMID: 21990948 DOI: 10.3748/wjg.v17.i32.3672] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
6 Kastelein F, Spaander M, Biermann K, Vucelic B, Kuipers E, Bruno M. Role of Acid Suppression in the Development and Progression of Dysplasia in Patients with Barrett’s Esophagus. Dig Dis 2011;29:499-506. [DOI: 10.1159/000331513] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
7 Goldman A, Shahidullah M, Goldman D, Khailova L, Watts G, Delamere N, Dvorak K. A novel mechanism of acid and bile acid-induced DNA damage involving Na+/H+ exchanger: implication for Barrett's oesophagus. Gut. 2010;59:1606-1616. [PMID: 20876775 DOI: 10.1136/gut.2010.213686] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
8 Hunt RH. Review article: the risks of oesophageal acid exposure - from minimal mucosal changes to malignancy. Aliment Pharmacol Ther Symp Series 2007;3:15-22. [DOI: 10.1111/j.1746-6342.2006.00069.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
9 Shah Gilani SN, Bass GA, Kharytaniuk N, Downes MR, Caffrey EF, Tobbia I, Walsh TN. Gastroesophageal Mucosal Injury after Cholecystectomy: An Indication for Surveillance? J Am Coll Surg 2017;224:319-26. [PMID: 27993699 DOI: 10.1016/j.jamcollsurg.2016.12.003] [Reference Citation Analysis]
10 Mazzadi SA, García AO, Salis GB, Chiocca JC. Peptic esophageal stricture: a report from Argentina. Diseases of the Esophagus 2004;17:63-6. [DOI: 10.1111/j.1442-2050.2004.00375.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Roberts NB. Review article: human pepsins - their multiplicity, function and role in reflux disease. Aliment Pharmacol Ther. 2006;24 Suppl 2:2-9. [PMID: 16939427 DOI: 10.1111/j.1365-2036.2006.03038.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 4.3] [Reference Citation Analysis]
12 Bernstein H, Bernstein C, Payne CM, Dvorak K. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol 2009; 15(27): 3329-3340 [PMID: 19610133 DOI: 10.3748/wjg.15.3329] [Cited by in CrossRef: 154] [Cited by in F6Publishing: 141] [Article Influence: 11.8] [Reference Citation Analysis]
13 Lord RV. Antireflux surgery for Barrett's oesophagus. ANZ J Surg 2003;73:234-6. [PMID: 12662234 DOI: 10.1046/j.1445-1433.2003.02569.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
14 Wu D, Qiu T, Zhang Q, Kang H, Yuan S, Zhu L, Zhu R. Systematic toxicity mechanism analysis of proton pump inhibitors: an in silico study. Chem Res Toxicol 2015;28:419-30. [PMID: 25626140 DOI: 10.1021/tx5003782] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
15 Desai KM, Soper NJ, Frisella MM, Quasebarth MA, Dunnegan DL, Brunt LM. Efficacy of laparoscopic antireflux surgery in patients with Barrett's esophagus. Am J Surg 2003;186:652-9. [PMID: 14672774 DOI: 10.1016/j.amjsurg.2003.08.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
16 Freitas MCD, Moretzsohn LD, Coelho LGV. Prevalence of Barrett's esophagus in individuals without typical symptoms of gastroesophageal reflux disease. Arq Gastroenterol 2008;45:46-9. [DOI: 10.1590/s0004-28032008000100009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Brillantino A, Monaco L, Schettino M, Torelli F, Izzo G, Cosenza A, Marano L, Di Martino N. Prevalence of pathological duodenogastric reflux and the relationship between duodenogastric and duodenogastrooesophageal reflux in chronic gastrooesophageal reflux disease. Eur J Gastroenterol Hepatol 2008;20:1136-43. [PMID: 18946360 DOI: 10.1097/MEG.0b013e32830aba6d] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
18 Karamanolis G, Vanuytsel T, Sifrim D, Bisschops R, Arts J, Caenepeel P, Dewulf D, Tack J. Yield of 24-hour esophageal pH and bilitec monitoring in patients with persisting symptoms on PPI therapy. Dig Dis Sci. 2008;53:2387-2393. [PMID: 18322797 DOI: 10.1007/s10620-007-0186-6] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
19 Andrew B, Alley JB, Aguilar CE, Fanelli RD. Barrett’s esophagus before and after Roux-en-Y gastric bypass for severe obesity. Surg Endosc 2018;32:930-6. [DOI: 10.1007/s00464-017-5768-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
20 Roesly HB, Khan MR, Chen HD, Hill KA, Narendran N, Watts GS, Chen X, Dvorak K. The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: the role of deoxycholic acid. Am J Physiol Gastrointest Liver Physiol. 2012;302:G864-G872. [PMID: 22301112 DOI: 10.1152/ajpgi.00340.2011] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
21 Baptissart M, Vega A, Maqdasy S, Caira F, Baron S, Lobaccaro JM, Volle DH. Bile acids: from digestion to cancers. Biochimie. 2013;95:504-517. [PMID: 22766017 DOI: 10.1016/j.biochi.2012.06.022] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 7.3] [Reference Citation Analysis]
22 Schiffman SC, Li Y, Xiao D, Li X, Aiyer HS, Martin RC. The resistance of esophageal adenocarcinoma to bile salt insult is associated with manganese superoxide dismutase expression. J Surg Res 2011;171:623-30. [PMID: 20638682 DOI: 10.1016/j.jss.2010.04.038] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
23 Bredenoord AJ, Smout AJ. Refractory gastrooesophageal reflux disease: . European Journal of Gastroenterology & Hepatology 2008;20:217-23. [DOI: 10.1097/meg.0b013e3282f1cc39] [Cited by in Crossref: 25] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
24 Thiagarajan P, Jankowski JA. Why is there a change in patterns of GE cancer? Recent Results Cancer Res 2012;196:115-40. [PMID: 23129370 DOI: 10.1007/978-3-642-31629-6_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
25 Lock G. Physiology and pathology of the oesophagus in the elderly patient. Best Pract Res Clin Gastroenterol 2001;15:919-41. [PMID: 11866485 DOI: 10.1053/bega.2001.0250] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
26 Upton MP, Nishioka NS, Ransil BJ, Rosenberg SJ, Puricelli WP, Zwas FR, Shields HM. Multilayered epithelium may be found in patients with Barrett's epithelium and dysplasia or adenocarcinoma. Dig Dis Sci 2006;51:1783-90. [PMID: 16967312 DOI: 10.1007/s10620-006-9243-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
27 Franchimont D, Van Laethem J, Devière J. Argon plasma coagulation in Barrett's esophagus. Gastrointestinal Endoscopy Clinics of North America 2003;13:457-66. [DOI: 10.1016/s1052-5157(03)00040-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
28 Maret-Ouda J, Wahlin K, Artama M, Brusselaers N, Färkkilä M, Lynge E, Mattsson F, Pukkala E, Romundstad P, Tryggvadóttir L, von Euler-Chelpin M, Lagergren J. Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries. JAMA Oncol 2018;4:1576-82. [PMID: 30422249 DOI: 10.1001/jamaoncol.2018.3054] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
29 Nakos A, Kouklakis G, Pitiakoudis M, Zezos P, Efraimidou E, Giatromanolaki A, Polychronidis A, Liratzopoulos N, Sivridis E, Simopoulos K. The histological and immunohistochemical aspects of bile reflux in patients with gastroesophageal reflux disease. Gastroenterol Res Pract 2011;2011:905872. [PMID: 21822428 DOI: 10.1155/2011/905872] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
30 Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H. Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res. 2005;589:47-65. [PMID: 15652226 DOI: 10.1016/j.mrrev.2004.08.001] [Cited by in Crossref: 352] [Cited by in F6Publishing: 314] [Article Influence: 20.7] [Reference Citation Analysis]
31 Vyas M, Celli R, Singh M, Patel N, Aslanian HR, Boffa D, Deng Y, Ciarleglio MM, Laine L, Jain D. Intestinal metaplasia around the gastroesophageal junction is frequently associated with antral reactive gastropathy: implications for carcinoma at the gastroesophageal junction. Hum Pathol 2020;105:67-73. [PMID: 32941964 DOI: 10.1016/j.humpath.2020.08.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Elias PS, Castell DO. The Role of Acid Suppression in Barrett's Esophagus. Am J Med 2017;130:525-9. [PMID: 28159599 DOI: 10.1016/j.amjmed.2016.12.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
33 Talley NJ, Abeygunasekera S. Bile reflux and Barrett's oesophagus: innocent bystander or sinister companion? Dig Liver Dis 2002;34:246-8. [PMID: 12038806 DOI: 10.1016/s1590-8658(02)80142-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
34 Schreiber S, Garten D, Sudhoff H. Pathophysiological mechanisms of extraesophageal reflux in otolaryngeal disorders. Eur Arch Otorhinolaryngol 2009;266:17-24. [DOI: 10.1007/s00405-008-0770-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
35 Jego M, Volant A, Faycal J, Doucet L, Andlauer E, Delalande AH, Cholet F, Nousbaum JB, Gouérou H, Robaszkiewicz M. Prevalence and topography of intestinal metaplasia in columnar lined esophagus. Gastroenterol Clin Biol 2007;31:601-6. [PMID: 17646787 DOI: 10.1016/s0399-8320(07)89437-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
36 Omae M, Fujisaki J, Shimizu T, Horiuchi Y, Ishiyama A, Yoshio T, Hirasawa T, Yamamoto Y, Tsuchida T, Igarashi M, Seto Y. Correlation of the location of superficial Barrett's esophageal adenocarcinoma (s-BEA) with the direction of gastroesophageal reflux. Endosc Int Open 2016;4:E515-20. [PMID: 27227107 DOI: 10.1055/s-0042-101757] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
37 Zhang T, Zhang F, Han Y, Gu Z, Zhou Y, Cheng Q, Zhu Y, Zhang C, Wang Y. A rat surgical model of esophageal metaplasia and adenocarcinoma-induced by mixed reflux of gastric acid and duodenal contents. Dig Dis Sci. 2007;52:3202-3208. [PMID: 17393326 DOI: 10.1007/s10620-007-9774-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
38 Chen H, Li X, Ge Z, Gao Y, Chen X, Cui Y. Rabeprazole combined with hydrotalcite is effective for patients with bile reflux gastritis after cholecystectomy. Can J Gastroenterol 2010;24:197-201. [PMID: 20352149 DOI: 10.1155/2010/846353] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
39 Boulton RA, Usselmann B, Mohammed I, Jankowski J. Barrett's esophagus: environmental influences in the progression of dysplasia. World J Surg. 2003;27:1014-1017. [PMID: 12879287 DOI: 10.1007/s00268-003-7054-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
40 Koek GH, Sifrim D, Lerut T, Janssens J, Tack J. Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors. Gut 2003;52:1397-402. [PMID: 12970129 DOI: 10.1136/gut.52.10.1397] [Cited by in Crossref: 213] [Cited by in F6Publishing: 168] [Article Influence: 11.2] [Reference Citation Analysis]
41 Konturek PC, Burnat G, Rau T, Hahn EG, Konturek S. Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line. Dig Dis Sci. 2008;53:597-605. [PMID: 17763959 DOI: 10.1007/s10620-007-9922-1] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 4.5] [Reference Citation Analysis]
42 Basnayake C, Geeraerts A, Pauwels A, Koek G, Vaezi M, Vanuytsel T, Tack J. Systematic review: duodenogastroesophageal (biliary) reflux prevalence, symptoms, oesophageal lesions and treatment. Aliment Pharmacol Ther 2021;54:755-78. [PMID: 34313333 DOI: 10.1111/apt.16533] [Reference Citation Analysis]
43 Katzka DA. Barrett's esophagus: surveillance and treatment. Gastroenterology Clinics of North America 2002;31:481-97. [DOI: 10.1016/s0889-8553(02)00020-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
44 Basu KK, Talwar V, de Caestecker JS. Effects of low-power argon plasma coagulation thermoablation of Barrett's epithelium on oesophageal motility. Eur J Gastroenterol Hepatol 2006;18:733-7. [PMID: 16772830 DOI: 10.1097/01.meg.0000216928.91618.9a] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
45 Majka J, Wierdak M, Szlachcic A, Magierowski M, Targosz A, Urbanczyk K, Krzysiek-Maczka G, Ptak-Belowska A, Bakalarz D, Magierowska K, Chmura A, Brzozowski T. Interaction of epidermal growth factor with COX-2 products and peroxisome proliferator-activated receptor-γ system in experimental rat Barrett's esophagus. Am J Physiol Gastrointest Liver Physiol 2020;318:G375-89. [PMID: 31928220 DOI: 10.1152/ajpgi.00410.2018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Hemmink GJ, Alvarez Herrero L, Bogte A, Bredenoord AJ, Bergman JJ, Smout AJ, Weusten BL. Esophageal motility and impedance characteristics in patients with Barrett’s esophagus before and after radiofrequency ablation. Eur J Gastroenterol Hepatol. 2013;25:1024-1032. [PMID: 23708277 DOI: 10.1097/meg.0b013e32836283dc] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
47 Woodland P, Sifrim D. The refluxate: The impact of its magnitude, composition and distribution. Best Pract Res Clin Gastroenterol. 2010;24:861-871. [PMID: 21126699 DOI: 10.1016/j.bpg.2010.09.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
48 Kastelein F, Spaander MC, Steyerberg EW, Biermann K, Valkhoff VE, Kuipers EJ, Bruno MJ. Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2013;11:382-388. [PMID: 23200977 DOI: 10.1016/j.cgh.2012.11.014] [Cited by in Crossref: 141] [Cited by in F6Publishing: 107] [Article Influence: 14.1] [Reference Citation Analysis]
49 Tack J. Review article: the role of bile and pepsin in the pathophysiology and treatment of gastro-oesophageal reflux disease: REVIEW: BILE AND PEPSIN IN THE TREATMENT OF GERD. Alimentary Pharmacology & Therapeutics 2006;24:10-6. [DOI: 10.1111/j.1365-2036.2006.03040.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
50 Ali I, Rafiee P, Hogan WJ, Jacob HJ, Komorowski RA, Haasler GB, Shaker R. Dickkopf homologs in squamous mucosa of esophagitis patients are overexpressed compared with Barrett's patients and healthy controls. Am J Gastroenterol 2006;101:1437-48. [PMID: 16863544 DOI: 10.1111/j.1572-0241.2006.00584.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
51 Wild CP, Hardie LJ. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions. Nat Rev Cancer. 2003;3:676-684. [PMID: 12951586 DOI: 10.1038/nrc1166] [Cited by in Crossref: 189] [Cited by in F6Publishing: 173] [Article Influence: 9.9] [Reference Citation Analysis]
52 Triadafilopoulos G. Acid and bile reflux in Barrett's esophagus: A tale of two evils. Gastroenterology 2001;121:1502-5. [DOI: 10.1053/gast.2001.30090] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
53 Izbéki F, Rosztóczy AI, Yobuta JS, Róka R, Lonovics J, Wittmann T. Increased prevalence of gallstone disease and impaired gallbladder motility in patients with Barrett's esophagus. Dig Dis Sci 2008;53:2268-75. [PMID: 18080764 DOI: 10.1007/s10620-007-0126-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
54 Xu XC. Risk factors and gene expression in esophageal cancer. Methods Mol Biol. 2009;471:335-360. [PMID: 19109788 DOI: 10.1007/978-1-59745-416-2_17] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
55 Jankowski J, Sharma P. Review article: approaches to Barrett’s oesophagus treatment-the role of proton pump inhibitors and other interventions. Aliment Pharmacol Ther. 2004;19 Suppl 1:54-59. [PMID: 14725580 DOI: 10.1111/j.0953-0673.2004.01839.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
56 Banki F, Demeester SR, Mason RJ, Campos G, Hagen JA, Peters JH, Bremner CG, Demeester TR. Barrett’s esophagus in females: a comparative analysis of risk factors in females and males. Am J Gastroenterol. 2005;100:560-567. [PMID: 15743352 DOI: 10.1111/j.1572-0241.2005.40962.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
57 Farré R. Pathophysiology of gastro-esophageal reflux disease: a role for mucosa integrity? Neurogastroenterol Motil 2013;25:783-99. [PMID: 23937353 DOI: 10.1111/nmo.12201] [Cited by in Crossref: 11] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
58 Song S, Byrd JC, Guha S, Liu KF, Koul D, Bresalier RS. Induction of MUC5AC mucin by conjugated bile acids in the esophagus involves the phosphatidylinositol 3-kinase/protein kinase C/activator protein-1 pathway. Cancer 2011;117:2386-97. [PMID: 24048786 DOI: 10.1002/cncr.25796] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
59 Bamehriz F, Dutta S, Pottruff CG, Allen CJ, Anvari M. Does laparoscopic Nissen fundoplication prevent the progression of Barrett's oesophagus? Is the length of Barrett's a factor? J Minim Access Surg 2005;1:21-8. [PMID: 21234140 DOI: 10.4103/0972-9941.15242] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
60 Tack J. Review article: role of pepsin and bile in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2005;22 Suppl 1:48-54. [PMID: 16042659 DOI: 10.1111/j.1365-2036.2005.02609.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
61 Sharma P. Barrett esophagus: will effective treatment prevent the risk of progression to esophageal adenocarcinoma? Am J Med 2004;117 Suppl 5A:79S-85S. [PMID: 15478857 DOI: 10.1016/j.amjmed.2004.07.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
62 Sharma P, Sampliner RE. Barrett esophagus. Curr Opin Gastroenterol 2002;18:471-8. [PMID: 17033323 DOI: 10.1097/00001574-200207000-00012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
63 Deviere J. Barrett's oesophagus: the new endoscopic modalities have a future. Gut. 2005;54:i33-i37. [PMID: 15711006 DOI: 10.1136/gut.2004.041574] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
64 Siersema PD, Yu S, Sahbaie P, Steyerberg EW, Simpson PW, Kuipers EJ, Triadafilopoulos G. Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use. Gastrointestinal Endoscopy 2006;63:581-6. [DOI: 10.1016/j.gie.2005.08.043] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
65 Sifrim D, Zerbib F. Gastroesophageal reflux disease: . Current Opinion in Gastroenterology 2002;18:447-53. [DOI: 10.1097/00001574-200207000-00009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
66 Orel R, Vidmar G. Do acid and bile reflux into the esophagus simultaneously? Temporal relationship between duodenogastro-esophageal reflux and esophageal pH. Pediatr Int. 2007;49:226-231. [PMID: 17445043 DOI: 10.1111/j.1442-200x.2007.02338.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
67 Zhang C, Liu ZK, Yu PW. Effects of bile reflux and intragastric microflora changes on lesions of remnant gastric mucosa after gastric operation. World J Gastroenterol 2004; 10(10): 1537-1539 [PMID: 15133869 DOI: 10.3748/wjg.v10.i10.1537] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
68 Tack J, Koek G, Demedts I, Sifrim D, Janssens J. Gastroesophageal Reflux Disease Poorly Responsive to Single-Dose Proton Pump Inhibitors in Patients without Barrett's Esophagus: Acid Reflux, Bile Reflux, or Both? Am J Gastroenterology 2004;99:981-8. [DOI: 10.1111/j.1572-0241.2004.04171.x] [Cited by in Crossref: 151] [Cited by in F6Publishing: 131] [Article Influence: 8.4] [Reference Citation Analysis]
69 Chen X, Oshima T, Shan J, Fukui H, Watari J, Miwa H. Bile salts disrupt human esophageal squamous epithelial barrier function by modulating tight junction proteins. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012;303:G199-208. [DOI: 10.1152/ajpgi.00454.2011] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
70 Orel R, Markovic S. Bile in the Esophagus: A Factor in the Pathogenesis of Reflux Esophagitis in Children: . Journal of Pediatric Gastroenterology and Nutrition 2003;36:266-73. [DOI: 10.1097/00005176-200302000-00020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
71 Bus P, Siersema PD, Verbeek RE, van Baal JW. Upregulation of miRNA-143, -145, -192, and -194 in esophageal epithelial cells upon acidic bile salt stimulation. Dis Esophagus 2014;27:591-600. [PMID: 24006894 DOI: 10.1111/dote.12112] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
72 Lippert E, Messmann H, Endlicher E. Are there gender-specific differences in reflux disease and Barrett's oesophagus? Journal of Men's Health 2011;8:16-20. [DOI: 10.1016/j.jomh.2010.12.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
73 Fass R. Gastroesophageal reflux disease revisited. Gastroenterol Clin North Am. 2002;31:S1-S10. [PMID: 12489466 DOI: 10.1016/s0889-8553(02)00046-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
74 Fass R, Sampliner RE. Barrett??s Oesophagus: Optimal Strategies for Prevention and Treatment. Drugs 2003;63:555-64. [DOI: 10.2165/00003495-200363060-00003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
75 Yaşar NF, Polat E, Duman M, Dağdelen M, Gunal MY, Uzun O, Akyuz C, Peker KD, Yol S. In vitro effects of rabeprazole on human pylorus tone. J Neurogastroenterol Motil 2015;21:217-21. [PMID: 25843074 DOI: 10.5056/jnm14126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
76 Brillantino A, Schettino M, Torelli F, Marano L, Porfidia R, Reda G, Grassia M, Braccio B, Di Martino N. Laparoscopic Nissen-Rossetti fundoplication is a safe and effective treatment for both Acid and bile gastroesophageal reflux in patients poorly responsive to proton pump inhibitor. Surg Innov. 2011;18:387-393. [PMID: 21742660 DOI: 10.1177/1553350611409593] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
77 Xia Y, Fang Y, Zhang H, Shen C, Wang P, Yan W, Li J, Xu Y, Shao S, Zhang Y, Yu X, Peng Z, Peng G, Chen W, Fang D. Role of Kruppel-Like Factor 5 in Deoxycholic Acid-Mediated Intestinal Transdifferentiation of Esophageal Squamous Epithelium. J Cancer 2019;10:5597-607. [PMID: 31632504 DOI: 10.7150/jca.30050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
78 Sital RR, Kusters JG, De Rooij FW, Kuipers EJ, Siersema PD. Bile acids and Barrett's oesophagus: a sine qua non or coincidence? Scand J Gastroenterol Suppl. 2006;11-17. [PMID: 16782617 DOI: 10.1080/00365520600664219] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
79 Guan B, Hoque A, Xu X. Amiloride and guggulsterone suppression of esophageal cancer cell growth in vitro and in nude mouse xenografts. Front Biol (Beijing) 2014;9:75-81. [PMID: 24999355 DOI: 10.1007/s11515-014-1289-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]